CN101371899B - Medicine for treating tympanitis - Google Patents
Medicine for treating tympanitis Download PDFInfo
- Publication number
- CN101371899B CN101371899B CN2008100793915A CN200810079391A CN101371899B CN 101371899 B CN101371899 B CN 101371899B CN 2008100793915 A CN2008100793915 A CN 2008100793915A CN 200810079391 A CN200810079391 A CN 200810079391A CN 101371899 B CN101371899 B CN 101371899B
- Authority
- CN
- China
- Prior art keywords
- parts
- otitis media
- grams
- erythromycin enteric
- drug composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a drug composition for treating otitis media, the drug composition is composed of raw materials with the following proportion by weight: 3 to 25 parts of amur corktree bark, 5 to 50 parts of honeysuckle flower, 3 to 35 parts of common anemarrhena rhizome, 2 to 20 parts of borneol, 0.125 to 15 parts of erythromycin enteric-coated tablets, 1 to 3 parts of raw pricklyash peel and 20 to 50 parts of sesame aroma oil, the amur corktree bark, the honeysuckle flower, the common anemarrhena rhizome, the borneol, the erythromycin enteric-coated tablets and the raw pricklyash peel are respectively groundinto powder, evenly mixed, soaked in the sesame aroma oil, bottled and sealed to prepare oil solution. The use of the drug composition for treating patients with otitis media has short treatment time, low cost, high cure rate of more than 90 percent and no relapse.
Description
Technical field
The invention belongs to a kind of Chinese patent medicine, be specifically related to a kind of pharmaceutical composition for the treatment of otitis media.
Background technology
Otitis media is a kind of disease of harm humans health, gives people's work, daily life, cultural life brings serious injury, has stayed great worry and misery, as untimely treatment, can cause tympanic member perforation, even deaf, and be converted into disease such as encephalitis.Acute suppurative otitis media, under hospital's conventional therapy, can temporarily control the state of an illness, cure rate can reach 30 percent, and most of patients is converted into chronic otitis media or secretory otitis media, does not have good method to go radical cure now to chronic, secreted, suppurative otitis media like this.But also exist the course of treatment long, easily recurrence, problems such as medical expense height.
Summary of the invention
The present invention is exactly at the problems referred to above, and a kind of treatment acute and chronic is provided, secreted, and the suppurative otitis media medicine, the cure rate that mainly solves otitis media is not high, easily recurrence, difficult radical cure, the problem that medical expense is high.
The present invention is by the following technical solutions: a kind of pharmaceutical composition for the treatment of otitis media, and it is made up of the following weight proportion raw material: 3～25 parts of Cortex Phellodendris, 5～50 parts of Flos Loniceraes, 3～35 parts of the Rhizoma Anemarrhenaes, 2～20 parts of Borneolum Syntheticums, 0.125～15 part of erythromycin enteric-coated tablet, 1～3 part of Pericarpium Zanthoxyli, 20～50 parts of Oleum Sesamis, preparation method: with Cortex Phellodendri, Flos Lonicerae, the Rhizoma Anemarrhenae, Borneolum Syntheticum, erythromycin enteric-coated tablet, Pericarpium Zanthoxyli are ground into powdery, mix homogeneously respectively, be soaked in the Oleum Sesami oil preparation that bottling is sealed to form again.
The present invention compares with prior art has following beneficial effect: medicine of the present invention adopts suitable antiinflammatory composition, strengthen and carry out antiinflammatory, sterilization, use this medicine can eliminate the cause of disease, focus, control infection does not influence work, is in and can operates, treatment time is short, expense is low, and cure rate does not recur more than 90%.
The present invention proves without any side effects through the treatment of routine patient surplus 300.Model case is as follows:
1, Yang Zhengliang, the man, 52 years old, new cities and towns, Yuanqu County, Yuncheng Shangguan people from village, the driver suffers from otitis media (suppurative) for a long time, and calendar year 2001 learns that the back with one bottle of this medicine oil preparation, after using according to the method described above, cured not recurrence so far, mobile phone: 13835955822 on the 15th
2. the beam people people, man, 27 years old, Wenxi County's crossdrift township osiery people from village.Suffered from the ears secretory otitis media in 1981, after curing with this oil preparation, not recurrence so far.
3. a horse young waiter in a wineshop or an inn, man, 18 years old, the horizontal East Village people in Jiangxian County Heng Shui town.Nineteen ninety is suffered from otitis media, with not recurrence so far behind this medicine oil preparation.
4, Zhao Yueying, the woman, 75 years old, Hou Jiao village, Wenxi County's crossdrift township, stone casket resident organizes the peasant, suffers from the ears otitis media, and does not have recurrence after the medication so far in 50 years old.Her son's phone: 13994891102
5, An Ziyi, the man, 50 years old, the chief of office of Houma City the People's Hospital was after learning in 2006, with not having recurrence so far after the treatment of this oil preparation.Phone: 0357-4223131 mobile phone: 13934073968
6, Wang Fengye, the woman, 34 years old, Lane three, north, Houma City new people lane, No. 18, eastern seven alleyways, 2005 through others' introduction, with not having recurrence so far after this medicine oil preparation treatment.Phone: 0357-4281805
The specific embodiment
Embodiment 1: a kind of pharmaceutical composition for the treatment of otitis media, and it is made up of the following weight proportion raw material: Cortex Phellodendri 3 grams, Flos Lonicerae 5 grams, the Rhizoma Anemarrhenae 3 grams, Borneolum Syntheticum 2 grams, erythromycin enteric-coated tablet 0.125 gram, Pericarpium Zanthoxyli 1 gram, Oleum Sesami 20 grams are with Cortex Phellodendri, Flos Lonicerae, the Rhizoma Anemarrhenae, Borneolum Syntheticum, erythromycin enteric-coated tablet, Pericarpium Zanthoxyli are ground into powdery, mix homogeneously respectively, be soaked in the Oleum Sesami, bottling is sealed to form oil preparation again.
Embodiment 2: a kind of pharmaceutical composition for the treatment of otitis media, and it is made up of the following weight proportion raw material: Cortex Phellodendri 14 grams, Flos Lonicerae 27.5 grams, the Rhizoma Anemarrhenae 19 grams, Borneolum Syntheticum 11 grams, erythromycin enteric-coated tablet 7.5625 grams, Pericarpium Zanthoxyli 2 grams, Oleum Sesami 35 grams are with Cortex Phellodendri, Flos Lonicerae, the Rhizoma Anemarrhenae, Borneolum Syntheticum, erythromycin enteric-coated tablet, Pericarpium Zanthoxyli are ground into powdery, mix homogeneously respectively, be soaked in the Oleum Sesami, bottling is sealed to form oil preparation again.
Embodiment 3: a kind of pharmaceutical composition for the treatment of otitis media, and it is made up of the following weight proportion raw material: Cortex Phellodendri 25 grams, Flos Lonicerae 50 grams, the Rhizoma Anemarrhenae 35 grams, Borneolum Syntheticum 20 grams, erythromycin enteric-coated tablet 15 grams, Pericarpium Zanthoxyli 3 grams, Oleum Sesami 50 grams are with Cortex Phellodendri, Flos Lonicerae, the Rhizoma Anemarrhenae, Borneolum Syntheticum, erythromycin enteric-coated tablet, Pericarpium Zanthoxyli are ground into powdery, mix homogeneously respectively, be soaked in the Oleum Sesami, bottling is sealed to form oil preparation again.
When using this medicine,, oil preparation is splashed in ear with the alcohol swab rod, pus do not occur after three days every day three times, but necessary logotype 10-15 day ability drug withdrawal just can reach the purpose of healing earlier with the in ear alcohol wash.
Claims (1)
1. pharmaceutical composition for the treatment of otitis media, it is characterized in that: it is made up of the following weight proportion raw material: 3～25 parts of Cortex Phellodendris, 5～50 parts of Flos Loniceraes, 3～35 parts of the Rhizoma Anemarrhenaes, 2～20 parts of Borneolum Syntheticums, 0.125～15 part of erythromycin enteric-coated tablet, 1～3 part of Pericarpium Zanthoxyli, 20～50 parts of Oleum Sesamis are with Cortex Phellodendri, Flos Lonicerae, the Rhizoma Anemarrhenae, Borneolum Syntheticum, erythromycin enteric-coated tablet, Pericarpium Zanthoxyli are ground into powdery, mix homogeneously respectively, be soaked in the Oleum Sesami oil preparation that bottling is sealed to form again.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100793915A CN101371899B (en) | 2008-09-16 | 2008-09-16 | Medicine for treating tympanitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100793915A CN101371899B (en) | 2008-09-16 | 2008-09-16 | Medicine for treating tympanitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101371899A CN101371899A (en) | 2009-02-25 |
| CN101371899B true CN101371899B (en) | 2011-04-27 |
Family
ID=40446399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100793915A Expired - Fee Related CN101371899B (en) | 2008-09-16 | 2008-09-16 | Medicine for treating tympanitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101371899B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102935112A (en) * | 2012-11-03 | 2013-02-20 | 逄瑞莲 | Traditional Chinese medicine for treating acute and chronic otitis media suppurative |
| CN104940632A (en) * | 2015-07-08 | 2015-09-30 | 李新梅 | Traditional Chinese medicine for treating lung channel wind-heat type secretory otitis media and preparation method thereof |
| CN105535772A (en) * | 2016-01-15 | 2016-05-04 | 胥丹 | Traditional Chinese medicine composition for treating secretory otitis media |
| CN112933114A (en) * | 2021-02-08 | 2021-06-11 | 吴占强 | Carbuncle-removing hearing-improving oil for treating otitis media |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1255362A (en) * | 1999-10-29 | 2000-06-07 | 刘开祥 | Exterior-applied Chinese patent medicine for treating tympanitis |
| CN1785301A (en) * | 2005-11-07 | 2006-06-14 | 仲崇玉 | Ready prepared chinese medicine 'erjingling' drops for treating tympanitis and its preparation method |
| CN101129889A (en) * | 2007-08-20 | 2008-02-27 | 陈江 | Coix Seed Oral Liquid |
-
2008
- 2008-09-16 CN CN2008100793915A patent/CN101371899B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1255362A (en) * | 1999-10-29 | 2000-06-07 | 刘开祥 | Exterior-applied Chinese patent medicine for treating tympanitis |
| CN1785301A (en) * | 2005-11-07 | 2006-06-14 | 仲崇玉 | Ready prepared chinese medicine 'erjingling' drops for treating tympanitis and its preparation method |
| CN101129889A (en) * | 2007-08-20 | 2008-02-27 | 陈江 | Coix Seed Oral Liquid |
Non-Patent Citations (4)
| Title |
|---|
| 刘素琴.仙方活命饮在耳鼻喉科临床上应用.《浙江中医药大学学报》.2007,第31卷(第3期),345,347. * |
| 吴西学.知柏地黄汤治疗小儿顽固性耳疳.《现代中医药》.1988,(第2期),40. * |
| 罗克强.中医辨证论治及中西医结合治疗慢性化脓性中耳炎.《中国中西医结合耳鼻喉科杂志》.2004,第12卷(第6期),305-307. * |
| 马恩明等.耳康粉治疗化脓性中耳炎、外耳道炎的初步观察(摘要).《第三届第四次全国中西医结合耳鼻喉科学术会论文汇编》.2002,31. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101371899A (en) | 2009-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101371899B (en) | Medicine for treating tympanitis | |
| CN101612278A (en) | The medicine for external use of treatment pyogenic type contaminated wounds | |
| CN102178748B (en) | External medicament for treating ulcer | |
| CN102068617A (en) | Pure Chinese herbal medicine inflammation-diminishing and sterilizing suspension liniment and preparation method thereof | |
| CN109464328A (en) | Plant type bacterio static itching-relieving liquid | |
| CN103751491A (en) | Medicament for treating dermatophytosis, psoriasis, dermatitis and flat wart, and treating method | |
| CN101099764A (en) | Traditional Chinese medicine for treating oral ulcer | |
| CN100471512C (en) | Medicinal wine for treating rheumatism and rheumatoid disease and its prepn | |
| CN102210778A (en) | Medicine for treating scapulohumeral periarthritis and preparation method thereof | |
| CN101152216A (en) | Traditional Chinese medicine for treating chronic suppurative otitis media | |
| CN105816551A (en) | Medicinal film used for treating gynecological diseases and maintaining female external genital organs, and production method thereof | |
| CN102366393A (en) | Snake oil liniment | |
| CN1093924A (en) | A kind of specific drug for the treatment of multiple tinea | |
| CN103893553B (en) | A kind of surface of a wound Chinese medicine compound prescription film and preparation method thereof | |
| CN101152389A (en) | Traditional Chinese medicine for treating cestodiasis | |
| CN101513485B (en) | Medicament for treating tinea | |
| CN102579938B (en) | Spray for curing gingivitis | |
| CN101279032A (en) | External use medicament for curing itch | |
| CN101152314A (en) | Traditional Chinese medicine for treating diaper dermatitis of infants | |
| CN103585459A (en) | Formula Chinese herbal medicine for treatment of viscus inflammation and illnesses by in vitro drip without oral administration | |
| CN1137917A (en) | Compound jiabing ear drops and preparation method thereof | |
| CN102283825A (en) | Medicament with broad-spectrum bactericidal effect | |
| CN105343278A (en) | Traditional Chinese medicine composition for infant itching dispelling | |
| CN1084627C (en) | Traditional Chinese medicinal plaster for treating psoriasis | |
| CN100402056C (en) | Medicine for curing toothache and its treating method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110427 Termination date: 20120916 |